The Aperio Blog
Begin With the End in Mind: Are You Ready for First-in-Human Clinical Trials?
You’ve been moving steadily from discovery into preclinical, and based on the data, your molecule will be advancing into First-in-Human clinical trials. But with funds limited, resources tight and many conflicting priorities, how do you know where to begin to make sure your organization is ready for clinical trials?
Watch our presentation moderated by Aperio COO Suzanne Kincaid along with her distinguished line-up of panelists from Nuventra Pharma Sciences, SpringWorks Therapeutics and G1 Therapeutics to learn what your organization needs to do to prepare for First-in-Human.
About Aperio Clinical Outcomes
Aperio Clinical Outcomes offers essential services for today’s complex, data-intensive oncology and rare disease clinical trials: rock-solid fit-for-purpose database development and management, unmatched analytics expertise, and powerful holistic tools that deliver the most coherent and actionable views of essential data. Just as important, in an industry flooded with promises, we make only one: We tell the truth, no matter what.
